Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Plasmacytoma × Radiation × Clear all

Sponsor

Conditions

Glioblastoma 21 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 13 Rectal Neoplasms 11 Prostatic Neoplasms 11 Gliosarcoma 11 Esophageal Neoplasms 9 Brain Neoplasms 9 Uterine Cervical Neoplasms 8 Lung Neoplasms 8 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Head and Neck Neoplasms 7 Pancreatic Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Squamous Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Glioma 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Endometrial Neoplasms 4 Burkitt Lymphoma 4 Breast Neoplasms, Male 4 Rhabdomyosarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 Calcium Dobesilate 2 Bortezomib 2 pomalidomide 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 ixazomib 1 daratumumab 1 carfilzomib 1 Specimen Handling 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Lenalidomide 1 Gemcitabine 1 Busulfan 1 Biopsy 1 2-(5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-(1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡